TOP STORIES

• ORGANIZATION Ease Foreign Price Adjustment Rules for New Drugs to Counter MFN Policy: FPMAJ
  June 15, 2026

• REGULATORY Pharma Wages Multi-Front Lobbying amid Push for Leaner Honebuto
  June 12, 2026

• REGULATORY Revolade, Bilanoa See First Generics in June Listing; 3 Final AGs on Roster
  June 11, 2026

• ACADEMIA Urine-Derived Stem Cells Eyed as New Drug Discovery Tool
  June 10, 2026

• REGULATORY Ishin Proposes Adding Drug, Device Makers to Chuikyo, LDP Wary
  June 10, 2026

• REGULATORY Cabinet Approves Immunization Act Revision to Cover Antibody Drugs
  June 10, 2026

• BUSINESS Moderna Japan Looks Beyond COVID for Next Growth Pillars
  June 9, 2026

• BUSINESS Oncolys Targets 300 Hospitals for Telomelysin Rollout
  June 9, 2026

• REGULATORY Japan Govt Likely to Slim Down Honebuto, but Details Remain Elusive
  June 8, 2026

• BUSINESS Takeda Swings to Loss after Booking Amitiza Litigation Charge
  June 8, 2026

• REGULATORY Ex-GSK Japan Head Calls for End to "Obsolete" 14-Day Prescription Limit
  June 5, 2026

• REGULATORY Trazenta Generic Outlook Remains Clouded as Court Upholds Treatment-Method Patents
  June 4, 2026

• BUSINESS Boehringer’s Japan Pharma Sales Up for 7th Straight Year, 10-Plus Launches Eyed by 2030
  June 4, 2026

• ORGANIZATION Time Ripe for Debate on Drug Spending Macroeconomic Indexing: INES
  June 3, 2026

• BUSINESS AbbVie Japan Says Sales-Doubling Plan on Track as Revenue Climbs 13.5%
  June 3, 2026

• ACADEMIA Tavneos Data Integrity Issue Could Spill Over to Japan, Investigator Warns
  June 2, 2026

• REGULATORY Novo’s Wegovy Nears Japan Approval as First MASH Therapy
  June 1, 2026

• BUSINESS Eylea Bio-AG Snags 60% Share in Just 3 Months, Outpacing Biosimilar
  May 29, 2026

• ORGANIZATION Global Pharma CEOs Urge Japan PM to Boost Support for Innovative Drugs
  May 29, 2026

• BUSINESS Bayer Regulatory Chief Hails Japan’s Review System, Flexibility on PI Waivers
  May 28, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »